As shown, in two prostate cancer cell lines (PC-3 and DU-145) and in two colon cancer cell lines (HCT-116 and DLD-1), FTS and GroA inhibited cell growth, while the combined treatment was significantly more effective than each of the treatments alone. The gene discussed is AKTIP; the disease is prostate carcinoma.